Latest / AudioScholar Rheumatology Weekly
Golimumab: ~half without psoriasis drug-free at 10 years
Editor's Pick: Drug-Free Remission in Early Peripheral Spondyloarthritis, including Psoriatic Arthritis: 10-year follow-up from the CRESPA trial (Arthritis & Rheumatology, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning vasculitis risk stratification and early biologic therapy, the steroid-sparing treat-to-target agenda in lupus, and remission, tapering and refractory disease in inflammatory arthritis, with a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.